GENEVA, Aug. 21 -- SHENZHEN LOONGEN BIOTECHNOLOGY CO., LTD. filed a patent application (CN2025/077164) for “HUMANIZED DESIGNER RECEPTORS EXCLUSIVELY ACTIVATED BY DESIGNER DRUGS”. With publication no. WO/2026/170394, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 19/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....